Abbreviations
- Apo2L/TRAIL:
-
Apo2 ligand/TNF-α-related apoptosis-inducing ligand
- CIBA:
-
Centro de Investigación Biomédica de Aragón (Centre for Biomedical Research of Aragón)
- CIMA:
-
Centro de Investigación Médica Aplicada (Centre for Applied Medical Research)
- CNIC:
-
Centro Nacional de Investigaciones Cardiovasculares (Spanish National Centre for Cardiovascular Research)
- CNIO:
-
Centro Nacional de Investigaciones Oncológicas (Spanish National Centre for Cancer Research)
- DNGR-1:
-
Dendritic cell NK lectin group receptor 1
- ESAT-6:
-
Early secreted antigenic target of 6 kDa
- FDA:
-
Food and Drug Administration
- GEIT:
-
Grupo Español de Inmunoterapia (Spanish Immunotherapy Group)
- HBV:
-
Hepatitis B virus
- IIS:
-
Instituto de Investigación Sanitaria (Institute for Health Research)
- MTBVAC:
-
Mycobacterium tuberculosis vaccine
- PD-1:
-
Programmed death 1
- poly I:C:
-
Polyinosinic: polycytidylic acid
- SEI:
-
Sociedad Española de Inmunología (Spanish Society for Immunology)
Acknowledgments
Bristol-Myers Squibb and Miltenyi Biotec funded this scientific event.
Conflict of interest
The authors declare no conflict of interest. Alberto Anel and Julián Pardo were conference organizers.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Anel, A., Martínez-Lostao, L. & Pardo, J. Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain. Cancer Immunol Immunother 64, 1067–1069 (2015). https://doi.org/10.1007/s00262-015-1732-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-015-1732-2